Jose M. Lizcano
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Publisher Correction: Polyamine-dependent metabolic shielding regulates alternative splicing.
Journal: Nature
Published: January 21, 2026
MAPK ERK5 is a novel regulator of MHC-I in cancer cells.
Journal: Cell communication and signaling : CCS
Published: September 30, 2025
Understanding Ibrilatazar's mechanism of action: Addressing concerns about autophagy in cancer Therapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: April 08, 2025
ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 06, 2024
Chitinase 3-like 1 is neurotoxic in multiple sclerosis patient-derived cortical neurons.
Journal: Clinical and translational medicine
Published: September 06, 2024
Polyamine-dependent metabolic shielding regulates alternative splicing.
Journal: Nature
Published: January 23, 2024
TRIB3 silencing promotes the downregulation of Akt pathway and PAX3-FOXO1 in high-risk rhabdomyosarcoma.
Journal: Experimental hematology & oncology
Published: December 13, 2023
MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists.
Journal: Cell death & disease
Published: August 29, 2023
Methuosis Contributes to Jaspine-B-Induced Cell Death.
Journal: International journal of molecular sciences
Published: June 03, 2022
The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival.
Journal: Cellular and molecular life sciences : CMLS
Published: May 23, 2022
Last Updated: 09/26/2026